ATLASC4 Therapeutics (CCCC) earnings date: Nov 5, 2026
C4 Therapeutics (CCCC) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$0.20.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CCCC
| Last price | $3.29 (-2.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the C4 Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
C4 Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on C4 Therapeutics. You can switch it off at any time.
Alert me before CCCC reportsFree to start. Creating an account takes under a minute.
Notify me when C4 Therapeutics reports
Track CCCC free Add C4 Therapeutics to a free ATLAS watchlist and see its next report date in one place.
CCCC earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.20 |
| Last report | Aug 11, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +27.1% |
| Average move around a report | ±9.3% (last 5) |
| Sector | Healthcare · Biotechnology |
C4 Therapeutics earnings history: last 5 reports
C4 Therapeutics last reported on Aug 11, 2026: EPS of -$0.18 against an estimate of -$0.23 (+21.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.23 | -$0.18 | +21.7% | Beat | +7.7% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +19.7% |
| May 12, 2026 | -$0.26 | -$0.20 | +23.1% | Beat | +16.1% |
| May 4, 2026 | $0.78 | $0.87 | +11.5% | Beat | +1.7% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CCCC
See the fair value, the probability range and the earnings history of C4 Therapeutics on its ATLAS page.
C4 Therapeutics (CCCC) stock analysisPlans from €3.99 a month.
C4 Therapeutics earnings: frequently asked questions
When does C4 Therapeutics (CCCC) report earnings?
C4 Therapeutics is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CCCC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.20 per share (USD). Estimates can change before the report.
How often does CCCC beat earnings estimates?
Of its last 5 reports with a recorded result, C4 Therapeutics beat the EPS estimate 5 times; the average surprise was +27.1%. Past results do not predict the next one.
How much does CCCC move around earnings?
Over its last 5 reports the stock moved an average of 9.3% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did C4 Therapeutics beat earnings estimates last quarter?
C4 Therapeutics last reported on Aug 11, 2026: EPS of -$0.18 against an estimate of -$0.23 (+21.7% surprise), a beat.
How much does CCCC usually move in a day?
On a normal trading day the ATLAS model puts CCCC’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer